We Develop Proprietary Peptide Drugs for Outpatient Therapy
Our programs include:
- Refractory Ascites
- Lung Diseases:
– Acute Respiratory Distress Syndrome (ARDS)
– Pulmonary Fibrosis (PF)
– Pulmonary Hypertension (PH)
- Cancer Immunotherapy
- Refractory Hypertension
AsahiKasei, PeptiDream, and Shionogi are our partners/investors.
We welcome additional partners for in-/out-licensing/co-development and go-to-market.
Please contact us:
11812 N Creek Parkway N, Ste. 101
Bothell, WA 98011 USA